Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 8 studies | 33% ± 13% | |
| enterocyte | 4 studies | 24% ± 2% |
Insufficient scRNA-seq data for expression of HHLA2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 98% | 395.33 | 87 / 89 | 78% | 51.46 | 707 / 901 |
| pancreas | 96% | 100.82 | 316 / 328 | 71% | 15.46 | 127 / 178 |
| intestine | 72% | 2559.95 | 700 / 966 | 85% | 27.42 | 447 / 527 |
| stomach | 65% | 107.05 | 232 / 359 | 78% | 22.26 | 222 / 286 |
| lung | 81% | 162.40 | 469 / 578 | 27% | 14.95 | 310 / 1155 |
| spleen | 68% | 19.72 | 165 / 241 | 0% | 0 | 0 / 0 |
| brain | 51% | 13.36 | 1343 / 2642 | 0% | 0 | 0 / 705 |
| esophagus | 6% | 2.90 | 82 / 1445 | 36% | 15.10 | 66 / 183 |
| prostate | 38% | 12.02 | 94 / 245 | 0% | 0.01 | 1 / 502 |
| peripheral blood | 34% | 15.27 | 316 / 929 | 0% | 0 | 0 / 0 |
| bladder | 0% | 0 | 0 / 21 | 24% | 9.42 | 121 / 504 |
| uterus | 6% | 5.72 | 10 / 170 | 5% | 1.56 | 24 / 459 |
| liver | 7% | 2.48 | 16 / 226 | 2% | 0.20 | 9 / 406 |
| ovary | 4% | 1.11 | 8 / 180 | 2% | 0.14 | 7 / 430 |
| thymus | 5% | 1.19 | 31 / 653 | 0% | 0 | 0 / 605 |
| breast | 3% | 18.04 | 16 / 459 | 0% | 0 | 0 / 1118 |
| adipose | 2% | 0.59 | 21 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 2% | 0.22 | 4 / 258 | 0% | 0 | 0 / 230 |
| skin | 1% | 0.27 | 19 / 1809 | 0% | 0.01 | 1 / 472 |
| blood vessel | 1% | 0.61 | 12 / 1335 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.06 | 3 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.02 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0031295 | Biological process | T cell costimulation |
| GO_0042104 | Biological process | positive regulation of activated T cell proliferation |
| GO_0001819 | Biological process | positive regulation of cytokine production |
| GO_0050852 | Biological process | T cell receptor signaling pathway |
| GO_0001817 | Biological process | regulation of cytokine production |
| GO_0005575 | Cellular component | cellular_component |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | HHLA2 |
| Protein name | HERV-H LTR-associating protein 2 (Human endogenous retrovirus-H long terminal repeat-associating protein 2) HERV-H LTR-associating 2 |
| Synonyms | |
| Description | FUNCTION: Through interaction with TMIGD2, costimulates T-cells in the context of TCR-mediated activation. Enhances T-cell proliferation and cytokine production via an AKT-dependent signaling cascade. . |
| Accessions | C9JD07 C9JY43 ENST00000467282.5 C9JY13 ENST00000462629.5 ENST00000491820.5 C9J7D0 ENST00000467562.5 [Q9UM44-2] H7C523 Q9UM44 ENST00000482099.1 ENST00000463019.7 ENST00000357759.9 [Q9UM44-1] ENST00000467761.6 [Q9UM44-1] ENST00000489514.6 [Q9UM44-1] |